Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies
Related Experiment Video
Updated: Jan 5, 2026

09:06
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
Published on: February 3, 2023
1.9K
Nicola L Lawson1, Carly I Dix2, Paul W Scorer1
1Precision Medicine, Oncology R&D, AstraZeneca, Cambridge, UK.
Abstract:
An amendment to this paper has been published and can be accessed via a link at the top of the paper.

